While certain minority groups are more likely to be diagnosed with dementia than their white counterparts, they may also be less likely to be eligible for new disease-slowing treatments, a new study finds. Cognitive, or mental, impairment in Black, Hispanic and Asian patients is more likely to be caused by forms of dementia unrelated to…  read on >  read on >

More than 160,000 people around the world have cystic fibrosis, and supplementing with vitamins C and E could help reduce the damaging inflammation in their lungs, according to new research. “Cystic fibrosis is a genetic disease that is associated with increased inflammation, and like many inflammatory diseases, it comes with a large amount of oxidative…  read on >  read on >

FRIDAY, Sept. 30, 2022 (HealthDay News) – The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig’s disease. But approval of the drug, called Relyvrio, is bound to stir new questions, with some doubting the strength of data supporting its…  read on >  read on >

More than 1 million Americans attempted suicide in 2020, and a new study is hinting at a potential way to reduce that risk: prescription folic acid. The study, of more than 800,000 Americans in a health care database, found that when people were on prescription folic acid, their likelihood of being treated for self-harm or…  read on >  read on >

Eating well and exercising can make for a longer life, and that holds true for former smokers, too, a new study shows. Researchers found that of nearly 160,000 former smokers, those who exercised, ate healthfully and limited their drinking were less likely to die over the next couple of decades, versus their counterparts with less-healthy…  read on >  read on >

Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports. After lengthy COVID infections, two kidney transplant patients on immune-suppressing drugs to prevent organ rejection developed a mutated version of SARS-CoV-2 resistant to remdesivir, according to researchers at NYU Grossman School of Medicine and…  read on >  read on >